Search results for "Crohn"

showing 10 items of 379 documents

Dzīves kvalitāte pacientiem ar iekaisīgo zarnu slimībām Latvijā

2017

Ievads: čūlains kolīts (ČK) un Krona slimība (KS) ir divas galvenās neizārstējamās iekaisīgu zarnu slimības (IZS), kuras bez slimībai specifiskajiem simptomiem būtiski ietekmē arī pacientu dzīves kvalitāti (DzK). Darba mērķi: Novērtēt pacientu ar IZS dzīves kvalitāti, korelāciju starp slimības gaitu un DzK, salīdzināt ČK un KS pacientu dzīves kvalitāti un noskaidrot, vai pastāv korelācija starp DzK un klīniskajiem un demogrāfiskiem rādītājiem. Materiāls un metodes: Tika atlasīti gan stacionēti, gan ambulatori pacienti, kuriem tika lūgts aizpildīt IZS anketu (IZSA), novērtējot sociālos, emocionālos u.c. aspektus, kā arī otru anketu ar vispārīgiem un demogrāfiskiem datiem. Rezultāti: Kopā pēt…

Quality of life (QOL)Crohn’s Disease (CD)Inflammatory Bowel Disease Questionnaire (IBDQ)Ulcerative Colitis (UC)Inflammatory Bowel Disease (IBD)Medicīna
researchProduct

QSAR methods for the discovery of new inflammatory bowel disease drugs

2013

Inflammatory bowel disease (IBD) represents an important class of chronic gastrointestinal tract disease. And although there are already several useful treatments to reduce and control the symptoms, there is still no cure. One drug discovery technique used is the computer-aided (in silico) discovery approach which has largely demonstrated efficacy. Computational techniques, when used in combination with traditional drug discovery methodology, greatly increase the chance of drug discovery in a sustainable and economical fashion.This review aims to provide the most recent and important advances of in silico IBD drug discovery. While this review is mainly focused on QSAR methods, especially th…

Quantitative structure–activity relationshipCrohn's diseaseDrug discoverybusiness.industryIn silicoQuantitative Structure-Activity RelationshipDiseaseInflammatory Bowel Diseasesmedicine.diseaseBioinformaticsUlcerative colitisInflammatory bowel diseaseDrug DiscoverymedicineComputer-Aided DesignHumansMolecular topologybusinessExpert Opinion on Drug Discovery
researchProduct

Small Bowel Perforations: What the Radiologist Needs to Know

2016

The incidence of small bowel perforation is low but can develop from a variety of causes including Crohn disease, ischemic or bacterial enteritis, diverticulitis, bowel obstruction, volvulus, intussusception, trauma, and ingested foreign bodies. In contrast to gastroduodenal perforation, the amount of extraluminal air in small bowel perforation is small or absent in most cases. This article will illustrate the main aspects of small bowel perforation, focusing on anatomical reasons of radiological findings and in the evaluation of the site of perforation using plain film, ultrasound, and multidetector computed tomography equipments. In particular, the authors highlight the anatomic key notes…

Radiology Nuclear Medicine and Imagingmedicine.medical_specialtyPerforation (oil well)Bowel perforation030218 nuclear medicine & medical imagingDiagnosis Differential03 medical and health sciences0302 clinical medicineIntussusception (medical disorder)Intestine SmallmedicineHumansRadiology Nuclear Medicine and imagingUltrasonographybusiness.industryCrohn diseasedigestive oral and skin physiology030208 emergency & critical care medicineDiverticulitisImage Enhancementmedicine.diseasedigestive system diseasesVolvulusBowel obstructionIntestinal PerforationRadiologyTomography X-Ray ComputedbusinessSmall bowel perforationSeminars in Ultrasound, CT and MRI
researchProduct

Utilidad de la ecografía con contraste intravenoso en la valoración de la recurrencia postquirúrgica de la enfermedad de Crohn

2016

Introducción: La recurrencia postquirúrgica es una situación frecuente en la enfermedad de Crohn (EC). La utilidad de la valoración clínica y analítica para el diagnóstico de recurrencia es limitado y actualmente, la técnica de referencia es la ileocolonoscopia que permite la valoración de la anastomosis ileocólica y/o del intestino proximal a la misma. Mediante el Índice de Rutgeerts se puede determinar la gravedad de la recurrencia que está relacionada con el desarrollo precoz de recurrencia clínica y necesidad de nueva cirugía. No obstante la técnica endoscópica, es una prueba con escasa aceptación por la paciente, no exenta de riesgos y limitaciones como la imposibilidad de franquear la…

RecurrenciaEcografíaEcografía con contrasteEnfermedad de CrohnUNESCO::CIENCIAS MÉDICAS ::Otras especialidades médicas:CIENCIAS MÉDICAS ::Otras especialidades médicas [UNESCO]
researchProduct

Epidemiological trends of pediatric IBD in Italy: A 10-year analysis of the Italian society of pediatric gastroenterology, hepatology and nutrition r…

2022

Introduction: The present study aimed at evaluating Italian epidemiological trends of pediatric inflammatory bowel diseases (IBD) over the period 2009–2018. Materials and methods: Data from 1969 patients enrolled in the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition Registry, by 49 pediatric IBD centers throughout the country, were analyzed, comparing three different time intervals (2009–2012, 2013–2015, 2016–2018). Results: The number of new IBD diagnoses ranged from 175 to 219 per year, evenly distributed over the examined period of time. From 2009 to 2018, the minimal incidence ranged from 1.59 to 2.04 /105 inhabitants aged < 18 years, with an overall slight p…

RegistrieDelayed DiagnosisHepatologyDelayed DiagnosiGastroenterologyPediatric IBDEpidemiological trendInflammatory Bowel DiseasesSettore MED/38 - Pediatria Generale E SpecialisticaCrohn DiseaseItalyEpidemiological trendsHumansColitis UlcerativeRegistriesChildEpidemiological trends; Italy; Pediatric IBDHuman
researchProduct

Estudio de la prevalencia de incontinencia fecal y alteración de la calidad de vida referida a la misma en pacientes con enfermedad inflamatoria inte…

2017

RESUMEN Objetivos: Conocer la prevalencia de la incontinencia fecal (IF) en los pacientes con Enfermedad Inflamatoria Intestinal Crónica (EIIC) y analizar su impacto en la calidad de vida. Métodos: Estudio prospectivo aleatorizado, descriptivo y analítico en 726 pacientes con EIIC (Enfermedad de Crohn (EC) y Colitis Ulcerosa (CU)) pertenecientes al departamento de salud del Hospital Clínico de Valencia. Se excluyen pacientes<18 años, pacientes con colitis indeterminadas, portadores de colostomías, ileostomías, reservorios o deterioro cognitivo. Se recogen variables demográficas, características fenotípicas de su EIIC, antecedentes personales y actividad de la EIIC. Se evalúa la calidad de v…

SF-36- Cuestionario calidad de vida en generalEP- Enfermedad perianalFactores de riesgo de incontinencia fecalCU- Colitis UlcerosaEIIC- Enfermedad Inflamatoria intestinal crónicaEC- Enfermedad de CrohnHCUV- Hospital Clínico Universitario de ValenciaIF- Incontinencia fecalIBDQ-32- Intestinal bowel disease questionaireECCO- European Crohn’s and colitis organitationCuestionario de wexnerCV- Calidad de vidaFIQLS- Cuestionario de calidad de vida en la incontinencia
researchProduct

I polimorfismi del gene IRGM sono associati al comportamento fistolizzante della malattia di Crohn.

2008

SNPMalattia di Crohn.
researchProduct

Shikonin promotes intestinal wound healing in vitro via induction of TGF-β release in IEC-18 cells

2013

The intestinal barrier is a complex system with a dynamic structure that is designed for the maintenance of homeostasis in healthy individuals. Ulcerative colitis, one of the main manifestations of inflammatory bowel disease, is characterized by an inadequate and delayed wound healing. Shikonin, the active principle in the root of Lithospermum erythrorhizon, has demonstrated its ability to attenuate dextran sulfate sodium-induced ulcerative colitis in mice. Moreover, the root of L. erythrorhizon has been used in traditional Chinese medicine for treatment of burns, anal ulcers, hemorrhoids and skin wounds. However, the effect of shikonin on intestinal wound healing is unknown. Using an in vi…

STAT3 Transcription FactorCell SurvivalPharmaceutical SciencePharmacologyInflammatory bowel diseaseCell Linechemistry.chemical_compoundCell MovementTransforming Growth Factor betamedicineAnimalsSTAT3Wound HealingCrohn's diseaseintegumentary systembiologybusiness.industryAnti-Inflammatory Agents Non-SteroidalTranscription Factor RelACell migrationNF-κBLithospermum erythrorhizonbiology.organism_classificationmedicine.diseaseUlcerative colitisRatsIntestineschemistryImmunologybiology.proteinWound healingbusinessNaphthoquinonesEuropean Journal of Pharmaceutical Sciences
researchProduct

Mouse models of inflammatory bowel disease.

2007

Animal models of intestinal inflammation are indispensable for our understanding of the pathogenesis of Crohn disease and Ulcerative colitis, the idiopathic forms of inflammatory bowel disease in humans. The clinical appearance of human IBD is heterogeneous, a fact that is also reflected by the steadily increasing number of mouse strains displaying IBD like intestinal alterations. The analysis of these models together with genetic studies in humans greatly enhanced our insights into immunoregulatory processes in the gut and led to the generally accepted hypothesis that a deregulated immune response against components of the intestinal microbiota is critically involved in IBD pathophysiology…

STAT3 Transcription FactorPharmaceutical ScienceMice Transgenicdigestive systemInflammatory bowel diseasePathogenesisMiceImmune systemImmunityMedicineAnimalsHumansCrohn's diseasebusiness.industryCrohn diseaseNF-kappa BSTAT4 Transcription Factormedicine.diseaseCadherinsInflammatory Bowel DiseasesUlcerative colitisdigestive system diseasesPathophysiologyImmunity InnateInterleukin-10Disease Models AnimalImmunologybusinessAdvanced drug delivery reviews
researchProduct

Resveratrol-induced xenophagy promotes intracellular bacteria clearance in intestinal epithelial cells and macrophages

2019

International audience; Autophagy is a lysosomal degradation process that contributes to host immunity by eliminating invasive pathogens and the modulating inflammatory response. Several infectious and immune disorders are associated with autophagy defects, suggesting that stimulation of autophagy in these diseases should be bene ficial. Here, we show that resveratrol is able to boost xenophagy, a selective form of autophagy that target invasive bacteria. We demonstrated that resveratrol promotes in vitro autophagy-dependent clearance of intracellular bacteria in intestinal epithelial cells and macrophages. These results were validated in vivo using infection in a transgenic GFP-LC3 zebra f…

Salmonella typhimuriumrestrictionResveratrolresveratrolMicechemistry.chemical_compound0302 clinical medicine[SDV.IDA]Life Sciences [q-bio]/Food engineeringImmunologieXenophagyImmunology and AllergyIntestinal MucosaZebrafishOriginal Research0303 health sciencessalmonella infectionbiologyChemistrycrohns-disease[SDV.IDA] Life Sciences [q-bio]/Food engineering3. Good healthCell biologyrégime alimentaire030220 oncology & carcinogenesisHost-Pathogen InteractionsAIEClcsh:Immunologic diseases. AllergyautophagysalmonelleTransgenesalmonellaImmunologyautophagieCell Line03 medical and health sciencesImmune systemxenophagyEscherichia coliAnimalsHumans030304 developmental biologyselective autophagyhealthy-volunteersmodelEnterocolitisMacrophagesIntracellular parasiteAutophagylife-span extensionautophagy;resveratrol;xenophagy;salmonella;AIECagent resveratrolEpithelial Cellsbiology.organism_classification[SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/BacteriologyCell cultureactivation[SDV.MP.BAC] Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriologyproteinlcsh:RC581-607Bacteria
researchProduct